Current Issue

Featured Article

Clinical Trial Update
EMBOLIZE: Bringing Randomized Evidence to Pelvic Vein Embolization
03/21/2026
Ronald S. Winokur, MD
Pelvic congestion, or pelvic venous disease (PeVD), is a chronic condition that causes pelvic pain in women. Dr. Winokur outlines the EMBOLIZE trial, a randomized study testing whether adding ovarian/pelvic vein embolization to venography...
Pelvic congestion, or pelvic venous disease (PeVD), is a chronic condition that causes pelvic pain in women. Dr. Winokur outlines the EMBOLIZE trial, a randomized study testing whether adding ovarian/pelvic vein embolization to venography...
Pelvic congestion, or pelvic...
03/21/2026
Cath Lab Digest
ultra-high-pressure balloons
The OPN NC Balloon in Complex PCI: Expanding What’s Possible
03/21/2026
Khaldoon Alaswad, MD
Dr. Alaswad shares his experience using the OPN NC for controlled ultra-high-pressure dilations to tackle resistant calcified lesions and support optimal stent expansion.
Dr. Alaswad shares his experience using the OPN NC for controlled ultra-high-pressure dilations to tackle resistant calcified lesions and support optimal stent expansion.
Dr. Alaswad shares his...
03/21/2026
Cath Lab Digest
Professional Life
(Podcast) From Arkansas to New Zealand: A Cath Lab Career Abroad
03/31/2026
Jason Money, RN, RCIS
Jason Money, RN, RCIS, draws on more than two decades in New Zealand’s public health system to explain how his program operates day to day. He describes working in a two-lab service that supports a busy angiography and percutaneous coronary...
Jason Money, RN, RCIS, draws on more than two decades in New Zealand’s public health system to explain how his program operates day to day. He describes working in a two-lab service that supports a busy angiography and percutaneous coronary...
Jason Money, RN, RCIS, draws on...
03/31/2026
Cath Lab Digest
Clinical Editor's Corner
Conversations in Cardiology: Pectus Excavatum and Coronary Compression in the Elderly
03/26/2026
Morton J. Kern, MD, MSCAI, FACC, FAHA; Steve Goldberg, MD; Dean J. Kereiakes, MD, FACC, MSCAI; Michael Ragosta, MD; Kenneth Rosenfield, MD, MHCDS; Carl L. Tommaso, MD
Dr. Kern and his expert colleagues discuss a case of pectus excavatum, a structural deformity of the anterior thoracic wall in which the sternum and rib cage produce a caved-in or sunken configuration of the chest. It can be congenital at...
Dr. Kern and his expert colleagues discuss a case of pectus excavatum, a structural deformity of the anterior thoracic wall in which the sternum and rib cage produce a caved-in or sunken configuration of the chest. It can be congenital at...
Dr. Kern and his expert...
03/26/2026
Cath Lab Digest
Case Report
Left Atrial Myxoma: Immediate Presentation, Diagnosis, and Treatment
03/20/2026
Richard Casazza, MAS; Neel Patel, MD; Allan Mattia, MD; Paul Saunders, MD; Arsalan Hashmi, MD; Greg Ribakove, MD
Cardiac myxomas are histologically benign tumors; however, they may lead to life-threatening complications. The authors share the case of a successful removal of myxoma with resolution of the patient's symptoms.
Cardiac myxomas are histologically benign tumors; however, they may lead to life-threatening complications. The authors share the case of a successful removal of myxoma with resolution of the patient's symptoms.
Cardiac myxomas are...
03/20/2026
Cath Lab Digest
Case Report & Discussion
“Wound to Amputation” — How Insurance Companies Are Dictating the Clinical Care of Chronic Limb-Threatening Ischemia
03/19/2026
Ivana Kumar; Anshita Kumari, MBBS; Kusum Lata, MD, FACC, FSCAI
Chronic limb-threatening ischemia (CLTI) is the most severe form of peripheral vascular disease, particularly involving the below-knee arteries. Management of CLTI hinges on a combination of guideline-directed medical therapy and timely...
Chronic limb-threatening ischemia (CLTI) is the most severe form of peripheral vascular disease, particularly involving the below-knee arteries. Management of CLTI hinges on a combination of guideline-directed medical therapy and timely...
Chronic limb-threatening...
03/19/2026
Cath Lab Digest
Commentary
Who Owns the Limb? Ethical Boundaries of Insurance Control Over Medical Decisions
03/18/2026
Anamika Fnu, MD; Sakshi Dixit, MD; Anmol Multani, MD; Akiva Rosenzveig, MD; Aravinda Nanjundappa MBBS, MD
Fnu et al examine how insurer-driven approvals can shape (and sometimes constrain) limb-salvage decision-making, and argue for clearer ethical boundaries that keep clinical judgment and patient goals at the center of care.
Fnu et al examine how insurer-driven approvals can shape (and sometimes constrain) limb-salvage decision-making, and argue for clearer ethical boundaries that keep clinical judgment and patient goals at the center of care.
Fnu et al examine how...
03/18/2026
Cath Lab Digest
Imaging Corner
Using 4D ICE for LAAO in a Rural Patient
03/17/2026
Patients in rural areas may have issues accessing cardiac care due to limited availability of anesthesia services. Transesophageal echocardiography (TEE) requires moderate to deep sedation, posing additional risk in this vulnerable population...
Patients in rural areas may have issues accessing cardiac care due to limited availability of anesthesia services. Transesophageal echocardiography (TEE) requires moderate to deep sedation, posing additional risk in this vulnerable population...
Patients in rural areas may have...
03/17/2026
Cath Lab Digest
Reimbursement Updates
CMS Final FY26 IPPS and CY26 OPPS Updates: What Hospitals, Physicians, and ASCs Need to Know
03/17/2026
Mike Church
Mike Church breaks down CMS’s finalized FY26 IPPS and CY26 OPPS rules, highlighting the payment, quality, coding/DRG, and site-of-care shifts hospitals, physicians, and ASCs need to plan for as more cardiovascular care moves to lower-cost...
Mike Church breaks down CMS’s finalized FY26 IPPS and CY26 OPPS rules, highlighting the payment, quality, coding/DRG, and site-of-care shifts hospitals, physicians, and ASCs need to plan for as more cardiovascular care moves to lower-cost...
Mike Church breaks down CMS’s...
03/17/2026
Cath Lab Digest
Case Report
Treating Chronic Venous Disease With a Modified Gun-Sight Technique  
03/16/2026
Matthew A. Tiede, MD
Dr. Tiede describes using a modified gun-sight recanalization approach to reconstruct an absent/occluded common femoral vein in a patient with severe chronic venous disease. A step-by-step discussion of the gun-sight technique is available in...
Dr. Tiede describes using a modified gun-sight recanalization approach to reconstruct an absent/occluded common femoral vein in a patient with severe chronic venous disease. A step-by-step discussion of the gun-sight technique is available in...
Dr. Tiede describes using a...
03/16/2026
Cath Lab Digest
Case Report
Bracing for the Unseen: Navigating the Unpredictable in Heart Failure
03/15/2026
Muhammad Imran Hanif, MBBS, FCPS, FSCAI, FRCP; Minahil Tariq Sheikh, MBBS, FCPS
Hanif and Sheikh report a dramatic heart failure presentation caused by an acutely ruptured sinus of Valsalva aneurysm with right-atrial shunting. It was successfully treated in the cath lab with transcatheter closure using an Amplatzer Duct...
Hanif and Sheikh report a dramatic heart failure presentation caused by an acutely ruptured sinus of Valsalva aneurysm with right-atrial shunting. It was successfully treated in the cath lab with transcatheter closure using an Amplatzer Duct...
Hanif and Sheikh report a...
03/15/2026
Cath Lab Digest
Subhead

Subscriber

Cath Lab Digest Newsletter

Clinical & Industry News

beta blockers
Stopping Beta-Blockers After Heart Attack Safe for Low-Risk Patients
04/02/2026
“In appropriately selected patients who survived a heart attack and do not have heart failure or left ventricular systolic dysfunction, routine continuation of beta-blockers indefinitely may not be necessary,” said Joo-Yong Hahn, MD.
“In appropriately selected patients who survived a heart attack and do not have heart failure or left ventricular systolic dysfunction, routine continuation of beta-blockers indefinitely may not be necessary,” said Joo-Yong Hahn, MD.
“In appropriately selected...
04/02/2026
Cath Lab Digest
AI Predictive Value
Including AI-Derived Heart Fat Measurement Improves Accuracy of Cardiovascular Disease Risk Prediction
04/02/2026
The study followed nearly 12,000 adults for approximately 16 years. Investigators applied AI to participants' standard coronary artery calcium scans to measure fat surrounding the heart.
The study followed nearly 12,000 adults for approximately 16 years. Investigators applied AI to participants' standard coronary artery calcium scans to measure fat surrounding the heart.
The study followed nearly 12,000...
04/02/2026
Cath Lab Digest
Leapfrog Group ASC Reporting
Ambulatory Surgery Center Reporting
The Leapfrog Group Announces Major Expansion of its ASC Public Reporting Program
04/02/2026
In July, Leapfrog will publicly report patient safety and quality data on thousands more ASCs on its website, allowing patients, purchasers and employers to search by procedure and compare ASCs side-by-side on evidence-based safety and...
In July, Leapfrog will publicly report patient safety and quality data on thousands more ASCs on its website, allowing patients, purchasers and employers to search by procedure and compare ASCs side-by-side on evidence-based safety and...
In July, Leapfrog will publicly...
04/02/2026
Cath Lab Digest
PCSK9 Inhibitors
Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Demonstrated Significantly Greater LDL-C Reductions at Eight Weeks Compared to Guideline-Recommended Oral Non-Statin Therapies When Added to Background Statins
03/31/2026
Treatment with enlicitide resulted in statistically significant and clinically meaningful reductions in low-density lipoprotein cholesterol (LDL-C) compared to bempedoic acid, ezetimibe or bempedoic acid with ezetimibe at eight weeks (day 56)...
Treatment with enlicitide resulted in statistically significant and clinically meaningful reductions in low-density lipoprotein cholesterol (LDL-C) compared to bempedoic acid, ezetimibe or bempedoic acid with ezetimibe at eight weeks (day 56)...
Treatment with enlicitide...
03/31/2026
Cath Lab Digest
ACC 2026
Medtronic ALERT Study Reveals AI-Enabled Clinician Alerts Significantly Improve Evaluation and Valve Intervention for Patients With Heart Valve Disease 
03/30/2026
The study utilized Tempus Next, an AI platform that identifies significant AS or MR patients who may meet guideline-indicated therapy criteria, but do not have a treatment plan in place.
The study utilized Tempus Next, an AI platform that identifies significant AS or MR patients who may meet guideline-indicated therapy criteria, but do not have a treatment plan in place.
The study utilized Tempus Next,...
03/30/2026
Cath Lab Digest
Roxana Mehran, MD
ACC 2026
Mount Sinai’s Roxana Mehran, MD, named President of the American College of Cardiology
03/30/2026
The American College of Cardiology (ACC) has named Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI, as its new President.
The American College of Cardiology (ACC) has named Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI, as its new President.
The American College of...
03/30/2026
Cath Lab Digest
Tricuspid Valve Intervention
Two-Year Data on Edwards Lifesciences’ EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits
03/30/2026
The new TRISCEND II trial data presented during a late-breaking featured research session at ACC.26 demonstrated confidence in two-year performance of TTVR with the EVOQUE system.
The new TRISCEND II trial data presented during a late-breaking featured research session at ACC.26 demonstrated confidence in two-year performance of TTVR with the EVOQUE system.
The new TRISCEND II trial data...
03/30/2026
Cath Lab Digest
ACC 2026
Landmark ALL-RISE Trial Results Presented at ACC.26: CathWorks FFRangio Demonstrates Similar Clinical Outcomes to Invasive Wire-based Physiology Assessment
03/30/2026
In a statement, Drs. Martin Leon, Ajay Kirtane, William Fearon, and Allen Jeremias stated: "The compelling results should serve as the impetus to increase adoption of physiology worldwide."
In a statement, Drs. Martin Leon, Ajay Kirtane, William Fearon, and Allen Jeremias stated: "The compelling results should serve as the impetus to increase adoption of physiology worldwide."
In a statement, Drs. Martin...
03/30/2026
Cath Lab Digest
ACC 2026
Boston Scientific Presents Two Late-Breaking Trials at ACC 2026 Highlighting New Evidence in Stroke Prevention for AFib and Treatment of Intermediate-Risk Pulmonary Embolism
03/30/2026
At the American College of Cardiology (ACC) 2026 Scientific Session, Boston Scientific presented results from two late-breaking randomized controlled trials evaluating device-based approaches in cardiovascular care: CHAMPION-AF, studying the...
At the American College of Cardiology (ACC) 2026 Scientific Session, Boston Scientific presented results from two late-breaking randomized controlled trials evaluating device-based approaches in cardiovascular care: CHAMPION-AF, studying the...
At the American College of...
03/30/2026
Cath Lab Digest
Prevalence of hypercortisolism in resistant hypertension patients from the MOMENTUM Study – credit Deepak L. Bhatt, MD, MPH, MBA, Director of Mount Sinai Fuster Heart Hospital
Resistant Hypertension
Nearly 30 Percent of Patients With Resistant Hypertension Have a Hormone Disorder Caused by High Cortisol
03/30/2026
MOMENTUM is described as the first U.S.-based study and the largest study to date to assess the prevalence of hypercortisolism among individuals with resistant hypertension. Researchers analyzed 1,086 participants across 50 centers in the...
MOMENTUM is described as the first U.S.-based study and the largest study to date to assess the prevalence of hypercortisolism among individuals with resistant hypertension. Researchers analyzed 1,086 participants across 50 centers in the...
MOMENTUM is described as the...
03/30/2026
Cath Lab Digest

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use